A genetically engineered influenza A virus with ras-dependent oncolytic properties

Cancer Research

Volumn 61, Issue 22, 2001, Pages 8188-8193

  Bergmann, Michael ^a   Romirer, Ingrid ^a,b   Sachet, Monika ^a   Fleischhacker, Reinhard ^a   Jakesz, Raimund ^a   Wolff, Klaus ^b   Pehamberger, Hubert ^b   Muster, Thomas ^b   García Sastre, Adolfo ^c   Palese, Peter ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; EFFECTOR CELL; ENDOTHELIUM CELL; GENETIC ENGINEERING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLUENZA VIRUS A; KERATINOCYTE; ONCOGENE N RAS; OPEN READING FRAME; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VIRUS CARCINOGENESIS; VIRUS EXPRESSION; VIRUS REPLICATION; VIRUS TRANSFORMATION;

ANIMALS; CELL TRANSFORMATION, VIRAL; CERCOPITHECUS AETHIOPS; EIF-2 KINASE; ENZYME ACTIVATION; GENES, RAS; HUMANS; INFLUENZA A VIRUS; MALE; MELANOMA; MICE; MICE, SCID; TRANSFECTION; TUMOR CELLS, CULTURED; VERO CELLS; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035890773     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. The double stranded RNA-activated protein kinase induced by interferon: Dsrna-PK
2. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon
3. The double-stranded RNA-dependent protein kinase PKR: Structure and function
4. PKR: A sentinel kinase for cellular stress
5. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced kinase
6. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells
7. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems
8. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication
9. Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2 α-kinase activation
10. Ras oncogenes in human cancer: A review
11. Activated N-Ras contributes to the chemoresistence of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis
12. HMEC-1: Establishment of an immortalized human microvascular endothelial cell line
13. Expression of the multidrug resistance-associated protein (MRP) and chemoresistance of human non-small-cell lung cancer cells
14. Single somatic ras gene point mutations in soft tissue malignant fibrous histiocytomas
15. A plasmid-based reverse genetics system for influenza virus
16. Transfectant influenza A viruses with long deletions in the NS1 protein grow efficiently in Vero cells
17. A permissive function of phosphoinositide 3-kinase in Ras activation mediated by inhibition of GTPase-activating proteins
18. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells
19. Intravenous administration of ONYX-015, a selectively replicating adenovirus, induces antitumoral efficacy
20. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas
21. An oncolytic herpes simplex virus type 1 selectively destroys diffuse liver metastases from colon carcinoma
22. Intergeneric poliovirus recombinants for the treatment of malignant glioma
23. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
24. The molecular basis of viral oncolysis: Usurpation of the ras signaling pathway by reovirus
25. Reovirus therapy of tumors with activated ras pathway
26. Replication-selective adenovirus as oncolytic agents
27. Conditionally replicating herpes vectors for cancer therapy
28. Use of preferentially replicating bacteria for the treatment of cancer
29. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine
30. Interferon-α resistance in a cutaneous T-cell lymphoma cell line is associated with lack of STAT 1 expression
31. Interferon-resistant human melanoma cells are deficient in ISGF3 components. STAT1, STAT2, and p48-ISGF3γ
32. Homozygous deletion of the α and β 1-interferon genes in human leukemia and derived cell lines
33. The tat protein protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase PKR
34. Specific phenotype restoration of an attenuated virus by knockout of a host resistance gene
35. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: Role of complex formation and the N-terminal domain
36. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein